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INTRODUCTION
Bcl-2 is a major anti-apoptotic molecule which is localized to the outer mitochondral membrane, endoplasmic reticulum and nuclear envelop (1) . Bcl-2 prevents cytochrome C release and inhibits the activation of caspases, a group of cysteine proteases that initiate the apoptotic process (2, 3) . However, recent studies suggest pleiotropic roles for bcl-2 in apoptosis regulation including modulation of Ca 2+ homeostasis, transcription factors, and signaling kinases (4) (5) (6) . Recent studies suggest that numerous cellular activities are influenced by the extracellular matrix (ECM). Cellmatrix interactions have been shown to greatly influence cell survival, and withdrawal of anchorage-dependent cells from their association with ECM results in apoptotic cell death (7, 8) . For example, apoptosis of secretory epithelial cells during involution of the mammary gland after lactation is accompanied by proteolytic degradation of the gland basement membrane (9) . Consistently, overexpression of stromelysin-1, a member of the matrix metalloproteinase (MMP) family of ECM-degrading enzymes, was shown to induce apoptosis in mammary epithelial cells in vitro and in transgenic mice (10) , possibly due to its effect on ECM integrity. When stromelysin-1 transgenic mice were crossed with mice overexpressing tissue inhibitor of metalloproteinase-1 (TIMP-1), a natural MMP inhibitor, apoptosis was significantly inhibited (11) , suggesting a role for MMPs and TIMPs in ECM-regulation of cell survival. Although the precise mechanisms by which TIMPs control cell survival remain undefined, their effect may be mediated by their ability to regulate proteolysis of both ECM components and other biologically relevant molecules. Indeed, TIMP-3 induction of apoptosis may be mediated by its inhibition of MMPs, resulting in stabilization of tumor necrosis factor (TNF)-a receptors on the cell surface (12) . However, apoptosis regulation by TIMPs may not be only related to their anti-proteolytic activity. For example, although TIMP-1 and TIMP-2 inhibition of MMP enzymatic activity is interchangeable, apoptosis regulation by these inhibitors was shown to be tissue-specific, suggesting that mechanisms other than inhibition of enzymatic activity may be involved (13) (14) (15) . Both TIMP-1 and TIMP-2 were also shown to regulate cell proliferation, suggesting that TIMP effects on cell survival may be mediated by yet undefined signaling pathways independent of their antiproteolytic activity (16) (17) (18) (19) . Indeed, TIMP-1 and TIMP-2 have been shown to stimulate tyrosine kinase and mitogen-activated protein kinase (MAPK) activity in human osteosarcoma cell line MG-63 (20). As a model to study the anti-apoptotic effects of bcl-2 in breast epithelial (BE) cells, we established stable transfectants of various BE cell lines overexpressing bcl-2. In this report, we investigated whether bcl-2 inhibition of apoptosis involves regulation of ECM molecules. Here we report that bcl-2 overexpression results in induction of TIMP-1 expression and that TIMP-1 expression in the absence of bcl-2 overexpression efficiently inhibits apoptosis. We present evidence that TIMP-1 inhibition of apoptosis involves modulation of signaling pathways, including activation of focal adhesion kinase (FAK).
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TIMP-1 enhance breast epithelial survival
Previous studies suggested an anti-apoptotic role for TIMP-1 (13, 14) . Since bcl-2 expression results in a high level of TIMP-1 expression in breast epithelial cells (last year's report), we examined whether TIMP-1 plays a direct role in the survival of MCF10A cells after exposure to apoptotic agents. To this end, MCF10A cells were exposed to IL0 2 in the presence or absence of exogenously added TIMP-1. Preliminary dose-dependence experiments showed that H 2 0 2 (250 to 500 uM) induced cell death, mostly by apoptosis as determined by nuclear morphological analysis (21). As shown in Table 1 , in the absence of TIMP-1, approximately 12% of cells remained viable following 48 hours of H 2 0 2 treatment. In the presence of TIMP-1 (500 ng/ml) cell survival increased to 23%. In contrast, similar amounts of TIMP-2 had no effect on H 2 0 2 -induced cell death in MCF10A cells (data not shown).
To eliminate the possibility that TIMP-1-enhanced cell survival following H,0 2 treatment was due to TIMP-1 mitogenic activity, MCF10A cells were incubated with Hthymidine for 48 hours, followed by serum-free culture for 24 hours and then examined for survival after H 2 0 2 treatment in the presence or absence of TIMP-1. These studies demonstrated similar results with 1.5-2 fold more 3 H-thymidine associated in the cells treated in the presence of TIMP-1, compared to that in H 2 0 2 -treated cells without TIMP-1 (data not shown,). This indicated that the increased cell survival rate following H 2 0 2 treatment in the presence of TIMP-1 results from an effect of TIMP-1 on cell survival, and not on proliferation.
To further investigate the role of TIMP-1 in the regulation of apoptosis in human breast epithelial cells, we introduced a TIMP-1-expression vector into MCF10A cells. TIMP-transfected MCF10A clones were isolated and the level of TIMP-1 expression was determined by immunoblot analysis. As shown in Fig. 1 , both intracellular and extracellular levels of TIMP-1 increased 3-6 folds in the TIMP-1-transfected MCF10A cells. The TIMP-1 expression levels in the TIMP-1-transfected MCF10A were comparable to those observed in the MCF10A cells overexpressing bcl-2. We next investigated whether the endogenous TIMP-1 could enhance cell survival against apoptotic stimuli including H 2 0 2 , Adriamycin. In addition, we compared the TIMP-1 overexpressing cells with the bcl-2 overexpressing cells. These studies demonstrated a similar rate of survival after these treatments in MCF10A cells overexpressing TIMP-1 or bcl-2 ( Fig. 2 A and B) . TIMP-1 inhibition of apoptosis was further confirmed by nuclear morphological analysis (Fig. 3) . Whereas the control cells showed fragmented nuclei that were consistent with nuclear morphological changes in apoptotic cells (21), no significant changes in nuclear morphology could be observed in either the TIMP-1-or the bcl-2 overexpressing cells. It should be mentioned that TIMP-1 overexpression had no effect on the basal levels of bcl-2 expression in the TIMP-1-transfected clones, suggesting that its effect on apoptosis is independent of the bcl-2 expression level (Fig. 4) .
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TIMP-1 inhibition of apoptosis does not depend on its ability to stabilize cellsubstrates or cell-cell interactions.
Survival of epithelial cells is dependent on their interaction with the ECM (7, 22) . Following loss of cell anchorage, epithelial cells undergo anoikis, the process of apoptosis caused by loss of substrate adhesion (7, 22) . TIMP-1 inhibition of apoptosis may result from its ability to stabilize cell-ECM interactions by inhibiting MMPs. If so, we hypothesized that TIMP-1 would not protect against apoptosis induced by loss of cellsubstrate interactions. To induce anoikis, the control and the MCF10A cells overexpressing TIMP-1 or bcl-2 were cultured in dishes coated with poly HEM A to prevent cell adhesion. After twenty-four hours, cell survival was determined by trypan blue exclusion assay. These studies showed that <20% of the control MCF10A cells remained viable in the polyHEMA-coated dishes consistent with induction of anoikis, as previously described (7). In contrast, ~ 80% of the bcl-2 or TIMP-1 overexpressing cells remained viable under the same conditions (Fig. 5A ). Cleavage of poly (ADP-ribose) polymerase (PARP) is an early event in the process of apoptosis resulting from the activation of caspase/Ced-3 family members (23). We therefore examined the PARP cleavage in TIMP-1-overexpressing cells cultured in polyHEMA-coated dishes. As shown in Fig. 5B , apoptosis-specific proteolytic cleavage of PARP (85-kDa fragment) was readily detected in suspension cultures of the control cells, whereas it was significantly inhibited in the bcl-2-or TIMP-1-overexpressing cells. Anchorageindependent survival of the control MCF10A, bcl-2-or TIMP-1-overexpressing cells was also evaluated by culturing cells in soft agar. As shown in Fig. 6 , > 80% of bcl-2-or TIMP-1-overexpressing cells remained viable even after 7 days of culture in soft agar, while < 20% of the control MCF10A cells survived. Thus, both bcl-2 and TIMP-1 can prevent anoikis in MCF10A cells. Taken together, these studies suggest that TIMP-1 inhibits caspase-mediated apoptosis independent of its ability to stabilize cell-substrate or cell-cell interactions.
Overexpression of TIMP-1 is associated with constitutive activation of the focal adhesion kinase (FAK) in an anchorage-independent manner.
Increasing evidence indicates that interactions of integrins with the ECM transduce biochemical signals that are mediated, in part, by the activation of the focal adhesion kinase (FAK) (22, 24-26). Neutralizing antibodies against integrins induce cell detachment followed by anoikis in epithelial cells, suggesting a role for integrin signaling in the regulation of anoikis (22, 27). Constitutively activated forms of FAK (tyrosine phosphorylated form) play a role in protection against anoikis (28) and free radicalinduced cell death (29), suggesting that FAK activity is critical for cell survival. Therefore, we examined whether the TIMP-1 anti-apoptotic activity involved the modulation of FAK activity. The expression levels of FAK were not altered by TIMP-1 overexpression, as determined by immunoblot analysis using an anti-FAK mAb (Fig.  7A) . We next examined whether TIMP-1 modulates FAK activity. To this end, the FAK protein was immunoprecipitated with an anti-FAK mAb and the active form was detected by immunoblot analysis using an anti-phosphotyrosine antibody. As shown in Fig. 7B , FAK is more efficiently activated in TIMP-1-overexpressing cells than in the control cells. Since studies showed that FAK activation requires cell anchorage (24-26), we asked whether TIMP-1 upregulation of FAK activation also required cell anchorage. To this end, we cultured the control and TIMP-1-overexpressing cells in suspension for 12 hours and examined tyrosine-phosphorylated FAK. As shown in •Bcl-2 -ß-actin If you are not a citizen or permanent resident of the United States, this agreement is contingent upon your holding and maintaining approved employment authorization. If you are on a nonimmigrant visa and work prior to or beyond approved employment authorization, the work will be considered "unauthorized employment" by the Immigration and Naturalization Service and a violation of status.
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